<?xml version="1.0" encoding="UTF-8"?><!-- generator="WordPress/2.8.2" -->
<rss version="0.92">
<channel>
	<title>Fuadel-hibri.ws</title>
	<link>http://fuadel-hibri.ws</link>
	<description>News About Fuad El-Hibri</description>
	<lastBuildDate>Mon, 30 Aug 2010 07:16:38 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	
	<item>
		<title>Emergent BioSolutions Hosts Symposium for Biomedical Research Scholars</title>
		<description>ROCKVILLE, Md., Aug 24, 2010 (BUSINESS WIRE) — Emergent BioSolutions   Inc. (NYSE:EBS) today hosted “Looking Beyond the Bench,” a symposium   organized for doctoral students enrolled in the NIH-Oxford-Cambridge   Scholars Program. The symposium featured Emergent executives, who, based   on their extensive experience in ...</description>
		<link>http://fuadel-hibri.ws/2010/08/emergent-biosolutions-hosts-symposium-for-biomedical-research-scholars/</link>
			</item>
	<item>
		<title>Colman McCarthy to Receive 2010 EL-HIBRI Peace Education Prize</title>
		<description>August  17,  2010  — The El-Hibri Charitable Foundation announced     today that prominent peace educator, nationally renowned columnist and     accomplished author Colman McCarthy has been selected as the recipient     of the  2010 El-Hibri Peace Education Prize. The Prize, which ...</description>
		<link>http://fuadel-hibri.ws/2010/08/colman-mccarthy-to-receive-2010-el-hibri-peace-education-prize/</link>
			</item>
	<item>
		<title>Emergent BioSolutions to Acquire Trubion Pharmaceuticals</title>
		<description>
	Trubion provides promising clinical-stage therapeutic candidates in the targeted disease areas of oncology and autoimmunity
	Trubion offers novel, protein therapeutic platforms and scientific expertise for developing innovative therapeutic candidates
	Transaction leverages large pharma partnerships to provide sales and marketing infrastructureidates
	Emergent reaffirms 2010 guidance for revenues and net income

ROCKVILLE, Md., Aug 12, 2010 ...</description>
		<link>http://fuadel-hibri.ws/2010/08/emergent-biosolutions-to-acquire-trubion-pharmaceuticals/</link>
			</item>
	<item>
		<title>Emergent Revises Upward 2010 Financial Forecast</title>
		<description>Company anticipates total revenues of $275 to $300 million and net income of $40 to $50 million

ROCKVILLE, MD, July 20, 2010 – Emergent BioSolutions  Inc. (NYSE:EBS) announced today that it is revising upwards its 2010  annual guidance to now reflect anticipated total revenues of $275 to  $300 ...</description>
		<link>http://fuadel-hibri.ws/2010/08/emergent-revises-upward-2010-financial-forecast/</link>
			</item>
	<item>
		<title>Maryland Governor Martin O’Malley Leads Ribbon Cutting Ceremony at Emergent’s Baltimore Manufacturing Facility</title>
		<description>ROCKVILLE, MD, July 16,  2010 – Emergent   BioSolutions Inc. (NYSE:EBS) today held a  ribbon cutting ceremony, led   by Governor Martin O’Malley and Fuad El-Hibri,    Emergent’s chairman and   chief executive officer, to mark the formal   opening of  ...</description>
		<link>http://fuadel-hibri.ws/2010/07/maryland-governor-martin-o%e2%80%99malley-leads-ribbon-cutting-ceremony-at-emergent%e2%80%99s-baltimore-manufacturing-facility/</link>
			</item>
	<item>
		<title>Emergent BioSolutions Awarded HHS Contract Valued at Up to $107 Million to Develop Large-Scale Manufacturing for BioThrax</title>
		<description>ROCKVILLE, Md., Jul 14, 2010

Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has  signed a contract valued at up to $107 million with the Office of the  Biomedical Advanced Research and Development Authority (BARDA) of the  Department of Health and Human Services (HHS), to develop and obtain ...</description>
		<link>http://fuadel-hibri.ws/2010/07/emergent-biosolutions-awarded-hhs-contract-valued-at-up-to-107-million-to-develop-large-scale-manufacturing-for-biothrax/</link>
			</item>
	<item>
		<title>The El-Hibri Foundation Launches Website</title>
		<description>The El-Hibri Foundation is a nonprofit organization with the goal of   fostering dialogue between various religions and encouraging nonviolent   solutions to global challenges affecting humankind.  The Foundation  has a  new website at www.elhibrifoundation.org.

The Foundation, lead by Chairman of the Board of Trustees Fuad  ...</description>
		<link>http://fuadel-hibri.ws/2010/07/the-el-hibri-foundation-launches-website/</link>
			</item>
	<item>
		<title>Emergent BioSolutions Hosts Biopreparedness Roundtable for NATO Parliamentarians</title>
		<description>ROCKVILLE, Md., Jul 12, 2010  (BUSINESS WIRE) –
Emergent BioSolutions Inc.  (NYSE:EBS) is hosting  “Bioterrorism Prevention, Preparedness and  Response,” a forum organized  for members of the North Atlantic Treaty  Organization (NATO)  Parliamentary Assembly (PA) to raise global  awareness of the importance  of ...</description>
		<link>http://fuadel-hibri.ws/2010/07/emergent-biosolutions-hosts-biopreparedness-roundtable-for-nato-parliamentarians/</link>
			</item>
	<item>
		<title>Emergent BioSolutions Completes Deliveries of BioThrax to Allied Foreign Governments</title>
		<description>ROCKVILLE, MD,  June 24, 2010 – Emergent  BioSolutions  Inc. (NYSE:EBS) led by CEO Fuad  El-Hibri,announced today that it has  completed separate international sales and deliveries of  BioThrax® (Anthrax Vaccine Adsorbed) to governments of several allied nations.    The company’s international sales efforts have ...</description>
		<link>http://fuadel-hibri.ws/2010/07/emergent-biosolutions-completes-deliveries-of-biothrax-to-allied-foreign-governments/</link>
			</item>
	<item>
		<title>Emergent BioSolutions to Participate in June 2010 Investor Conferences</title>
		<description>Fuad   El-Hibri, CEO of Emergent BioSolutions Inc., announces  that the   company        will be participating in the following investor   conferences during  June        2010:

	The Jefferies &#38; Company 2010 Global Life ...</description>
		<link>http://fuadel-hibri.ws/2010/06/emergent-biosolutions-to-participate-in-june-2010-investor-conferences/</link>
			</item>
</channel>
</rss>
